Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor

摘要

Methods and kits using a pharmaceutical composition for use in inhibiting ocular angiogenesis or fibrosis are provided herein, such that composition includes a pharmaceutically suitable carrier or diluent and an amount of the inhibitor composition effective to inhibit the angiogenesis or the fibrosis by inhibiting expression and/or activity of a galectin protein or a portion thereof.

主权项

1. A pharmaceutical composition for use in a method of treatment for at least one selected from: ocular angiogenesis, and ocular fibrosis, wherein the composition comprises a pharmaceutically suitable carrier or a diluent and an amount of the composition effective to inhibit or to modulate an activity of a galectin protein or portion thereof sufficient to inhibit the at least one from ocular angiogenesis or ocular fibrosis.